For decades, the focus of pediatric ophthalmology has been fixed on East Asia where myopia has reached epidemic proportions, affecting up to 90% of school-leavers. In contrast, Europe was long perceived as a region with relatively stable prevalence patterns, but recent environmental and behavioral shifts suggest that this picture is changing. In fact, a trio of comprehensive systematic reviews and meta-analyses published between 2025 and 2026 – encompassing data from nearly half a million individuals – suggests that the tide is turning.

Europe is no longer a bystander in the global myopia crisis; it is a region in transition, grappling with shifting demographics and a lack of standardized diagnostic protocols. These epidemiological patterns are not merely academic; they carry direct clinical implications, particularly for early detection and timely myopia management.

The numbers: A continent of contrasts

The collective data from these recent studies (1-3) place the overall prevalence of myopia in Europe somewhere between 23.5% and 24.9%. While this figure seems modest compared to Singapore or Hong Kong, the granularity of the data reveals a more concerning picture:

• The adolescent surge: In children, prevalence remains relatively low (approx. 3.3% to 5.5% in cycloplegic studies). However, as children transition into adolescence and early adulthood, the rates skyrocket, reaching nearly 50% in some cohorts.

• Geographical disparity: The "European average" masks extreme regional variations. While countries like Finland report rates as low as 11.9%, several regions, particularly in Southern Europe, show substantially higher figures, with some adolescent cohorts approaching 40–50% in school‑based studies. Projections for Spain, for instance, estimate a 30.2% prevalence by 2030. These trends suggest a growing public health burden for European healthcare systems

• The high myopia threat: Perhaps most concerning is the prevalence of high myopia (≤-6.00D), now affecting over 3% of the European population. This represents a ticking time bomb for future cases of retinal detachment, myopic macular degeneration, and glaucoma.

The "cycloplegia debate": Are we misdiagnosing Europe?

One of the most striking findings across these three papers is the impact of measurement techniques on reported data. The "Gold Standard" of cycloplegic refraction is not universally applied in European research, leading to significant variability and potential overestimation in prevalence. The studies show a clear discrepancy: non‑cycloplegic measurements tend to report higher myopia prevalence (up to 31.2%), whereas cycloplegic studies show more conservative values (around 18.9%). This raises an important point: part of the apparent increase in European prevalence may reflect methodological differences rather than a true epidemiological shift. While the upward trend is consistent across datasets, the magnitude of that increase should be interpreted with caution.

Drivers of change: Education and the urban jungle

Why is Europe changing? The researchers point to the "modern lifestyle" as the primary engine. While genetics provides the blueprint, the environment builds the myopia:

1. The "education effect:" The association between educational demands and myopia is well established, with a clear dose–response relationship between years of schooling and refractive error. In Europe, it is not education itself that has fundamentally changed, but rather the intensity and behaviors associated with modern learning environments, greater near‑work load, increased screen use, and reduced time outdoors. These shifts collectively contribute to the rising myopia risk observed in younger generations.

2. Outdoor deficit: Urbanization across the continent has led to a significant decrease in "lux-hours" - the time children spend in natural sunlight, which is known to trigger dopamine release in the retina and inhibit eye growth.

3. The digital proxy: While the "screen time" debate continues, researchers agree that digital devices serve as a proxy for increased near-work and decreased outdoor activity.

Clinical implications: From correction to management

The paradigm shift proposed by these recent publications is clear: the role of the European Eye Care Professionals must evolve from refractive correction to proactive management.

With the emergence of low-dose atropine, myopia control spectacles and contact lenses, and orthokeratology, the tools to slow progression are available. However, these tools require early identification. The meta-analyses suggest that the "window of opportunity" in European children is between the ages of 6 and 12, before the adolescent surge takes hold.

The bottom line

Europe stands at a crossroads. We are not yet at the crisis levels seen in Asia, but the upward trend is undeniable. The call to action from the 2025-2026 data is twofold: first, the urgent need for standardized protocols across all EU member states; and second, the integration of myopia management into primary eye care.

If we continue to view myopia as a simple refractive inconvenience rather than a progressive disease, we are effectively "blinding" ourselves to a looming public health crisis.

The European Myopia Network

The European Myopia Network (EMN) is an open educational and scientific initiative that brings together experts from across the majority of European countries (https://myopianetwork.eu/). The network conducts innovative research, shares key developments in myopia through curated educational content, and fosters collaboration among clinicians and researchers. EMN also hosts educational events, including the upcoming Myopia 2026 online meeting on June 5, which is free to attend. Membership, event participation, and all educational materials are provided at no cost. (https://miopia.pl/conference-2026/)